Sugi Predict

Sugi Predict / Compounds / SCHEMBL10114548

SCHEMBL10114548

SCHEMBL10114548

CC(C)N(C(=O)c1cccc(NC(=O)C2CCC(NS(=O)(=O)C(C)(C)C)CC2)c1)C(C)C

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 4/20 0.51
▸ NPY5R Q15761 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.47
▸ LMNA P02545 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ HTT P42858 2/20 0.46
▸ USP2 O75604 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ TP53 P04637 1/20 0.44
▸ GLA P06280 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ KCNK3 O14649 1/20 0.41
▸ KCNK9 Q9NPC2 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14424343 1.00 GAA (0.51) GAANPY5RALDH1A1LMNASMN1; SMN2
SCHEMBL13203858 0.88 ALDH1A1 (0.62) GAANPY5RALDH1A1LMNASMN1; SMN2
SCHEMBL10113327 0.88 ALDH1A1 (0.62) GAANPY5RALDH1A1LMNASMN1; SMN2
SCHEMBL10114899 0.87 GAA (0.53) GAAALDH1A1LMNASMN1; SMN2HTT
SCHEMBL14627641 0.87 GAA (0.53) GAAALDH1A1LMNASMN1; SMN2HTT
SCHEMBL10114552 0.87 NPY5R (0.51) GAANPY5RLMNAGLANPSR1
SCHEMBL14424348 0.87 NPY5R (0.51) GAANPY5RLMNAGLANPSR1
SCHEMBL13203866 0.87 GAA (0.50) GAANPY5RALDH1A1LMNASMN1; SMN2
SCHEMBL10113347 0.87 GAA (0.50) GAANPY5RALDH1A1LMNASMN1; SMN2
SCHEMBL13203864 0.86 GAA (0.54) GAANPY5RALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R GAA 3448/4885NPY5R 1/4885ALDH1A1 4558/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R GAA 3316/4885NPY5R 1/4885ALDH1A1 4599/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R GAA 3472/4885NPY5R 1/4885ALDH1A1 4517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.